CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.

The endocannabinoid anandamide (AEA) is released by macrophages and microglia on pathological neuroinflammatory conditions such as multiple sclerosis (MS). CD200 is a membrane glycoprotein expressed in neurons that suppresses immune activity via its receptor (CD200R) mainly located in macrophages/mi...

Full description

Bibliographic Details
Main Authors: Hernangómez, M, Mestre, L, Correa, F, Loría, F, Mecha, M, Iñigo, P, Docagne, F, Williams, R, Borrell, J, Guaza, C
Format: Journal article
Language:English
Published: 2012
_version_ 1797063672824070144
author Hernangómez, M
Mestre, L
Correa, F
Loría, F
Mecha, M
Iñigo, P
Docagne, F
Williams, R
Borrell, J
Guaza, C
author_facet Hernangómez, M
Mestre, L
Correa, F
Loría, F
Mecha, M
Iñigo, P
Docagne, F
Williams, R
Borrell, J
Guaza, C
author_sort Hernangómez, M
collection OXFORD
description The endocannabinoid anandamide (AEA) is released by macrophages and microglia on pathological neuroinflammatory conditions such as multiple sclerosis (MS). CD200 is a membrane glycoprotein expressed in neurons that suppresses immune activity via its receptor (CD200R) mainly located in macrophages/microglia. CD200-CD200R interactions contribute to the brain immune privileged status. In this study, we show that AEA protects neurons from microglia-induced neurotoxicity via CD200-CD200R interaction. AEA increases the expression of CD200R1 in LPS/IFN-γ activated microglia through the activation of CB(2) receptors. The neuroprotective effect of AEA disappears when microglial cells derive from CD200R1(-/-) mice. We also show that engagement of CD200R1 by CD200Fc decreased the production of the proinflammatory cytokines IL-1β and IL-6, but increased IL-10 in activated microglia. In the chronic phases of Theiler's virus-induced demyelinating disease (TMEV-IDD) the expression of CD200 and CD200R1 was reduced in the spinal cord. AEA-treated animals up-regulated the expression of CD200 and CD200R1, restoring levels found in sham animals together with increased expression of IL-10 and reduced expression of IL-1β and IL-6. Treated animals also improved their motor behavior. Because AEA up-regulated the expression of CD200R1 in microglia, but failed to enhance CD200 in neurons we suggest that AEA-induced up-regulation of CD200 in TMEV-IDD is likely due to IL-10 as this cytokine increases CD200 in neurons. Our findings provide a new mechanism of action of AEA to limit immune response in the inflamed brain.
first_indexed 2024-03-06T21:03:16Z
format Journal article
id oxford-uuid:3b93f84d-e7f9-41c8-b8dc-1763dab44877
institution University of Oxford
language English
last_indexed 2024-03-06T21:03:16Z
publishDate 2012
record_format dspace
spelling oxford-uuid:3b93f84d-e7f9-41c8-b8dc-1763dab448772022-03-26T14:08:32ZCD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3b93f84d-e7f9-41c8-b8dc-1763dab44877EnglishSymplectic Elements at Oxford2012Hernangómez, MMestre, LCorrea, FLoría, FMecha, MIñigo, PDocagne, FWilliams, RBorrell, JGuaza, CThe endocannabinoid anandamide (AEA) is released by macrophages and microglia on pathological neuroinflammatory conditions such as multiple sclerosis (MS). CD200 is a membrane glycoprotein expressed in neurons that suppresses immune activity via its receptor (CD200R) mainly located in macrophages/microglia. CD200-CD200R interactions contribute to the brain immune privileged status. In this study, we show that AEA protects neurons from microglia-induced neurotoxicity via CD200-CD200R interaction. AEA increases the expression of CD200R1 in LPS/IFN-γ activated microglia through the activation of CB(2) receptors. The neuroprotective effect of AEA disappears when microglial cells derive from CD200R1(-/-) mice. We also show that engagement of CD200R1 by CD200Fc decreased the production of the proinflammatory cytokines IL-1β and IL-6, but increased IL-10 in activated microglia. In the chronic phases of Theiler's virus-induced demyelinating disease (TMEV-IDD) the expression of CD200 and CD200R1 was reduced in the spinal cord. AEA-treated animals up-regulated the expression of CD200 and CD200R1, restoring levels found in sham animals together with increased expression of IL-10 and reduced expression of IL-1β and IL-6. Treated animals also improved their motor behavior. Because AEA up-regulated the expression of CD200R1 in microglia, but failed to enhance CD200 in neurons we suggest that AEA-induced up-regulation of CD200 in TMEV-IDD is likely due to IL-10 as this cytokine increases CD200 in neurons. Our findings provide a new mechanism of action of AEA to limit immune response in the inflamed brain.
spellingShingle Hernangómez, M
Mestre, L
Correa, F
Loría, F
Mecha, M
Iñigo, P
Docagne, F
Williams, R
Borrell, J
Guaza, C
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
title CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
title_full CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
title_fullStr CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
title_full_unstemmed CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
title_short CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
title_sort cd200 cd200r1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation
work_keys_str_mv AT hernangomezm cd200cd200r1interactioncontributestoneuroprotectiveeffectsofanandamideonexperimentallyinducedinflammation
AT mestrel cd200cd200r1interactioncontributestoneuroprotectiveeffectsofanandamideonexperimentallyinducedinflammation
AT correaf cd200cd200r1interactioncontributestoneuroprotectiveeffectsofanandamideonexperimentallyinducedinflammation
AT loriaf cd200cd200r1interactioncontributestoneuroprotectiveeffectsofanandamideonexperimentallyinducedinflammation
AT mecham cd200cd200r1interactioncontributestoneuroprotectiveeffectsofanandamideonexperimentallyinducedinflammation
AT inigop cd200cd200r1interactioncontributestoneuroprotectiveeffectsofanandamideonexperimentallyinducedinflammation
AT docagnef cd200cd200r1interactioncontributestoneuroprotectiveeffectsofanandamideonexperimentallyinducedinflammation
AT williamsr cd200cd200r1interactioncontributestoneuroprotectiveeffectsofanandamideonexperimentallyinducedinflammation
AT borrellj cd200cd200r1interactioncontributestoneuroprotectiveeffectsofanandamideonexperimentallyinducedinflammation
AT guazac cd200cd200r1interactioncontributestoneuroprotectiveeffectsofanandamideonexperimentallyinducedinflammation